Showing results (1-10 of 200) with videos related to
Sort By:
Pageof 20
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapyPeggy Marconi, Cornel Fraefel, Alberto L EpsteinMethods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Herpes simplex virus type 1-derived recombinant and amplicon vectorsCornel Fraefel, Peggy Marconi, Alberto L EpsteinMethods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapyCornel Fraefel, Peggy Marconi, Alberto L EpsteinMethods in Molecular Biology (Clifton, N.J.)|October 17, 2019
Preparation of Herpes Simplex Virus Type 1 (HSV-1)-Based Amplicon VectorsCornel Fraefel, Alberto L EpsteinMethods in Molecular Biology (Clifton, N.J.)|March 28, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectorsMatias E Melendez, Cornel Fraefel, Alberto L EpsteinCurrent Opinion in Drug Discovery & Development|March 6, 2010
HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseasesPeggy Marconi, Roberto Manservigi, Alberto L EpsteinAdvances in Experimental Medicine and Biology|January 5, 2010
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.Current Gene Therapy|October 28, 2005
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapyAlberto L Epstein, Peggy Marconi, Rafaela Argnani, et al.The Journal of General Virology|August 16, 2005
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunityHenning Lauterbach, Christine Ried, Alberto L Epstein, et al.Human Vaccines|May 24, 2008
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Elena Berto, et al.Pageof 20